Telomere Length and Genetic Anticipation in Lynch Syndrome
暂无分享,去创建一个
E. Guinó | V. Moreno | C. Lázaro | G. Capellá | L. Valle | I. Blanco | M. Navarro | M. Pineda | E. Borrás | Fernando Bellido | N. Seguí
[1] E. Guinó,et al. Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome , 2012, European Journal of Human Genetics.
[2] Margaret A. Strong,et al. Extreme Telomere Length Dimorphism in the Tasmanian Devil and Related Marsupials Suggests Parental Control of Telomere Length , 2012, PloS one.
[3] N. Rothman,et al. Association of Leukocyte Telomere Length with Colorectal Cancer Risk: Nested Case–Control Findings from the Shanghai Women's Health Study , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[4] S. Savage,et al. Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. , 2012, Mutation research.
[5] J. M. Taylor,et al. Bayesian Modeling for Genetic Anticipation in Presence of Mutational Heterogeneity: A Case Study in Lynch Syndrome , 2011, Biometrics.
[6] M. Ponz de Leòn,et al. Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome , 2011, Cancer.
[7] N. Royle,et al. Deficiency in DNA mismatch repair increases the rate of telomere shortening in normal human cells , 2011, Human mutation.
[8] M. Urioste,et al. Genetic Anticipation Is Associated with Telomere Shortening in Hereditary Breast Cancer , 2011, PLoS genetics.
[9] S. Ballereau,et al. TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres , 2011, Gut.
[10] Q. Wei,et al. Shortened Telomere Length Is Associated with Increased Risk of Cancer: A Meta-Analysis , 2011, PloS one.
[11] R. Pfeiffer,et al. The Association of Telomere Length and Cancer: a Meta-analysis , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[12] G. Giles,et al. Dependence of colorectal cancer risk on the parent‐of‐origin of mutations in DNA mismatch repair genes , 2011, Human mutation.
[13] S. Gruber,et al. A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome , 2010, Genetic epidemiology.
[14] R. Bertorelle,et al. Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers , 2010, British Journal of Cancer.
[15] M. Frazier,et al. Microsatellite instability in the peripheral blood leukocytes of HNPCC patients , 2010, Human mutation.
[16] J. Ford,et al. Longer Relative Telomere Length in Blood from Women with Sporadic and Familial Breast Cancer Compared with Healthy Controls , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[17] H. Pickett,et al. Human telomeres that contain (CTAGGG)n repeats show replication dependent instability in somatic cells and the male germline , 2009, Nucleic acids research.
[18] M. Blasco,et al. MSH2 deficiency abolishes the anticancer and pro‐aging activity of short telomeres , 2009, Aging cell.
[19] I. Bernstein,et al. Role for genetic anticipation in Lynch syndrome. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] S. Gruber,et al. Anticipation in lynch syndrome: still waiting for the answer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Richard M. Cawthon,et al. Telomere length measurement by a novel monochrome multiplex quantitative PCR method , 2009, Nucleic acids research.
[22] I. Bernstein,et al. A Parametric Model for Analyzing Anticipation in Genetically Predisposed Families , 2009, Statistical applications in genetics and molecular biology.
[23] M. Trková,et al. Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age , 2007, Cancer.
[24] D. Malkin,et al. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. , 2007, Cancer research.
[25] A. Piepoli,et al. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC , 2007, Clinical genetics.
[26] Yen-Pei Christy Chang,et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] I. Dokal,et al. Dyskeratosis congenita: telomerase, telomeres and anticipation. , 2005, Current opinion in genetics & development.
[28] P. Hutter,et al. Evidence for genetic anticipation in hereditary non-polyposis colorectal cancer , 2005, Human Genetics.
[29] J. Londoño-Vallejo. Telomere length heterogeneity and chromosome instability. , 2004, Cancer letters.
[30] E. Montgomery,et al. Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis , 2004, Clinical Cancer Research.
[31] H. Pickett,et al. Telomere instability detected in sporadic colon cancers, some showing mutations in a mismatch repair gene , 2004, Oncogene.
[32] T. Vulliamy,et al. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC , 2004, Nature Genetics.
[33] R. Scott,et al. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. , 2001, American journal of human genetics.
[34] J. Shay,et al. Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals , 1998, Human Genetics.
[35] N. Petrelli,et al. Establishment of a hereditary nonpolyposis colorectal cancer registry , 1996, Diseases of the colon and rectum.
[36] A. Cats,et al. Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. , 1994, Gut.
[37] C. Boland,et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. , 1993, Gastroenterology.